Home › Funds › MPM BioImpact LLC › STOK

MPM BioImpact LLC position in STOK

STOKE THERAPEUTICS INC · Health Care

MPM BioImpact LLC reported holding 723,314 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$23.7M, representing 1.44% of its reported portfolio and ranking #26 among its reported holdings. MPM BioImpact LLC has disclosed STOK holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)723.31K sh
Reported value held$23.67M
Portfolio Weight1.44%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's STOK position evolved

MPM BioImpact LLC first disclosed a stake in STOK in Q3 2024 at 479,452 shares (US$5.9M). The position peaked in Q1 2026 at 767,038 shares, worth US$25.0M. Across 8 filings, MPM BioImpact LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 723,314 shares valued at US$23.7M — a reduction of -43,724 shares quarter over quarter.. Notable position changes include a 43% increase in Q4 2024 (shares fell 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 479.45K $5.89M New
Q4 2024 685.83K $7.56M Add
Q1 2025 693.99K $4.62M Add
Q2 2025 789.70K $8.96M Add
Q3 2025 789.70K $18.56M Hold
Q4 2025 770.29K $24.45M Reduce
Q1 2026 767.04K $24.97M Hold
Q2 2026 723.31K $23.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has MPM BioImpact LLC held STOK?

MPM BioImpact LLC has disclosed STOK holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is MPM BioImpact LLC's current position in STOK?

As of Q2 2026, MPM BioImpact LLC holds 723.31K shares of STOK (STOKE THERAPEUTICS INC), valued at $23.67M, representing 1.44% of its reported portfolio and ranking #26.

Has MPM BioImpact LLC been buying or selling STOK?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in STOK. The position peaked in Q1 2026 at 767.04K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.